Shanghai Baolong Biotech Co.,LTD

Founded in 2016, BL Pharma is an innovative pharmaceutical company for the research and development, manufacture, commercialization of high technology generic drug, MAH licensed services, the introduction of imported APIs, formulations, etc. into the Chinese market. By fully utilizing cutting-edge formulation technologies, and with in-depth cooperation with strategic customers, BL Pharma now has 100+ generic projects in the pipeline currently being developed to commercialization. In total 8 drugs have approved.

At the same time, BL Pharms also holds advanced CRO/CMO capabilities, to provide the biotech customers one-shop services and solutions on drug bio-equivalency (BE) studies, drug formulation studies, API process optimization, and drug quality upgrading activities. As we are experts on drug regulatory affairs, drug application and registration are also within out service scope.

So far, BL Pharma has kept strong business links with some big pharmaceutical companies, contributing to their projects which on both of the clinical phase and launched stage.

In addition, BL Pharma can provide the service to import the drugs, and perform the registration of API to the customers. A very professional and experienced drug filing team, from both of technical and regulatory perspectives, is the key to the high success rate. As a result, a global API supplier network and strategic partnership has been well established with the global pharmaceutical companies from Europe, the United States, Japan, India.